CHRISTOPHER SCHMIDT: Open Payments
NPI 1881005213 · TERRE HAUTE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$691 in 44 payments from 13 companies in 2025. Trend: 2023 $1,468 · 2024 $1,064 · 2025 $691
Food & beverage: $691
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $154 |
| ABBVIE INC. | 13 | $149 |
| AstraZeneca Pharmaceuticals LP | 2 | $137 |
| GlaxoSmithKline, LLC. | 3 | $45 |
| Lundbeck LLC | 2 | $37 |
| Lilly USA, LLC | 2 | $32 |
| Novartis Pharmaceuticals Corporation | 1 | $29 |
| Phathom Pharmaceuticals, Inc. | 1 | $24 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
| PFIZER INC. | 1 | $19 |
Products named: FARXIGA, VRAYLAR, Ozempic, REXULTI, MOUNJARO, TRELEGY ELLIPTA, ENTRESTO, VOQUEZNA.
Industry payments across IN — which companies pay providers there.
